AksharChem India Q2 Profit Rs 13.32 Crore; Revenue Surges 80 Percent

CHEMICALS
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
AksharChem India Q2 Profit Rs 13.32 Crore; Revenue Surges 80 Percent

AksharChem India reported a major turnaround for the quarter ended September 30, 2026, swinging to a net profit of Rs 13.32 crore from a net loss of Rs 1.37 crore in the same period last year. Revenue jumped nearly 80% to Rs 160.48 crore, driven by strong operational performance. Additionally, the Board confirmed the re-appointment of Munjal M. Jaykrishna as MD & CEO for another three-year term, signaling leadership stability.

AksharChem India Reports Turnaround: Profit Reaches Rs 13.32 Crore

Revenue jumped to Rs 160.48 crore from Rs 89.30 crore; PAT hit Rs 13.32 crore vs loss of Rs 1.37 crore.

Reader Takeaway: Strong revenue growth and transition to profitability drive positive sentiment, while maintaining this momentum remains key.

What just happened

AksharChem India released its financial results for the quarter ended September 30, 2026, showcasing a robust recovery. The company reported a net profit of Rs 13.32 crore, a significant improvement over the net loss of Rs 1.37 crore recorded in the corresponding quarter of the previous fiscal year. Revenue from operations also saw a sharp climb, reaching Rs 160.48 crore compared to Rs 89.30 crore in Q2 of the previous year, marking a 79.7% year-on-year increase.

Why this matters

The company’s ability to scale revenue while successfully returning to profitability suggests improved demand in the specialty chemicals segment. For the half-year period ending September 30, 2026, the company has posted a total net profit of Rs 28.53 crore, a definitive reversal from the loss of Rs 0.66 crore seen in the same six-month window last year.

Board and Governance Update

At the board meeting held on October 19, 2026, the company ensured continuity by re-appointing Mr. Munjal M. Jaykrishna as Managing Director and CEO for a three-year term, subject to shareholder approval. The Board also revised the remuneration for Executive Director Mr. Sachin M. Jaykrishna and cleared his re-appointment for a further three-year term beginning August 2, 2027.

What to track next

Investors should monitor whether the company can maintain this high revenue growth trajectory in coming quarters. While the base effect of the previous year’s losses has been cleared, consistent margin management will be the next indicator of operational health.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.